MXPA05006889A - Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos. - Google Patents
Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.Info
- Publication number
- MXPA05006889A MXPA05006889A MXPA05006889A MXPA05006889A MXPA05006889A MX PA05006889 A MXPA05006889 A MX PA05006889A MX PA05006889 A MXPA05006889 A MX PA05006889A MX PA05006889 A MXPA05006889 A MX PA05006889A MX PA05006889 A MXPA05006889 A MX PA05006889A
- Authority
- MX
- Mexico
- Prior art keywords
- immunomodulatory
- inflammatory
- aromatic compounds
- proliferatory
- agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Abstract
La presente invencion se relaciona con compuestos de la formula (II) y sales y derivados fisiologicamente funcionales de los mismos (ver formula), para el uso como un medicamento.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10260800 | 2002-12-23 | ||
PCT/EP2003/014433 WO2004056797A1 (en) | 2002-12-23 | 2003-12-17 | Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05006889A true MXPA05006889A (es) | 2006-04-07 |
Family
ID=32667540
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05006890A MXPA05006890A (es) | 2002-12-23 | 2003-12-17 | Compuestos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos. |
MXPA05006889A MXPA05006889A (es) | 2002-12-23 | 2003-12-17 | Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05006890A MXPA05006890A (es) | 2002-12-23 | 2003-12-17 | Compuestos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos. |
Country Status (22)
Country | Link |
---|---|
EP (3) | EP2283898A1 (es) |
JP (3) | JP2006514023A (es) |
KR (1) | KR101107456B1 (es) |
CN (3) | CN1939896A (es) |
AT (2) | ATE450498T1 (es) |
AU (2) | AU2003299316A1 (es) |
BR (2) | BR0317687A (es) |
CA (2) | CA2509138A1 (es) |
CY (1) | CY1111851T1 (es) |
DE (1) | DE60330391D1 (es) |
DK (1) | DK1578741T3 (es) |
ES (1) | ES2368735T3 (es) |
IL (2) | IL169184A (es) |
MX (2) | MXPA05006890A (es) |
NO (2) | NO20052907L (es) |
NZ (1) | NZ541382A (es) |
PL (2) | PL377478A1 (es) |
PT (1) | PT1578741E (es) |
RU (2) | RU2386625C2 (es) |
SI (1) | SI1578741T1 (es) |
WO (1) | WO2004056797A1 (es) |
ZA (1) | ZA200504387B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012508205A (ja) * | 2008-11-07 | 2012-04-05 | 4エスツェー アクチェンゲゼルシャフト | Dhodhインヒビター及びメトトレキセートを含んで成る、自己免疫疾患を処理するための組合せ治療 |
TWI530286B (zh) * | 2009-05-04 | 2016-04-21 | 帕納特斯製藥格斯有限公司 | 作為抑制病毒化合物之抗發炎劑 |
US8686048B2 (en) | 2010-05-06 | 2014-04-01 | Rhizen Pharmaceuticals Sa | Immunomodulator and anti-inflammatory compounds |
WO2012109329A2 (en) | 2011-02-08 | 2012-08-16 | Children's Medical Center Corporation | Methods for treatment of melanoma |
RU2485112C1 (ru) * | 2012-04-26 | 2013-06-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Пермский государственный национальный исследовательский университет" | 4-(4-бромфенил)-4-оксо-2-{[3-(этоксикарбонил)-4,5-диметилтиен-2-ил]амино}-2-бутеновая кислота, обладающая противовоспалительной и анальгетической активностью |
JP6271806B2 (ja) * | 2014-04-11 | 2018-01-31 | パノプテス・ファーマ・ゲーエムベーハー | ウイルス静止化合物としての抗炎症剤 |
ES2960598T3 (es) * | 2014-05-08 | 2024-03-05 | Kiora Pharmaceuticals Gmbh | Compuestos para el tratamiento de enfermedades y trastornos oftálmicos |
CN110099907A (zh) | 2016-12-21 | 2019-08-06 | 拜欧赛里克斯公司 | 靶向蛋白质的噻吩并吡咯衍生物、组合物、方法及其用途 |
WO2022167402A1 (en) | 2021-02-02 | 2022-08-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of therapy comprising administering a therapeutically effective combination comprising a dhodh inhibitor and an idh inhibitor |
CA3215002A1 (en) | 2021-04-09 | 2022-10-13 | Christian Gege | Deuterated dhodh inhibitors |
TW202332433A (zh) | 2021-12-23 | 2023-08-16 | 德商埃慕尼克股份公司 | 含羧酸生物電子等排體之dhodh抑制劑 |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL186239B (nl) | 1975-06-05 | Hoechst Ag | Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze. | |
AU1526483A (en) * | 1982-06-14 | 1983-12-22 | Nippon Kayaku Kabushiki Kaisha | N-substituted-3,4,5,6-tetrahydrophthalamic acids |
ZA839187B (en) * | 1982-12-10 | 1984-07-25 | Ciba Geigy Ag | Amide compounds |
GB8311519D0 (en) * | 1983-04-27 | 1983-06-02 | Fisons Plc | Nitrogen heterocycles |
GB8323293D0 (en) * | 1983-08-31 | 1983-10-05 | Zyma Sa | Substituted flavene and thioflavene derivatives |
DE3402026A1 (de) | 1984-01-21 | 1985-07-25 | Basf Ag, 6700 Ludwigshafen | Neue 2-aminothiophenderivate |
DE3534440A1 (de) | 1985-09-27 | 1987-04-02 | Hoechst Ag | Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes |
DE3812225A1 (de) * | 1988-04-13 | 1989-10-26 | Basf Ag | Isoxazol(isothiazol)-5-carbonsaeureamide |
DE59009528D1 (de) * | 1989-09-22 | 1995-09-21 | Basf Ag | Carbonsäureamide. |
DE3932052A1 (de) * | 1989-09-26 | 1991-04-04 | Basf Ag | Oxazol- bzw. thiazolcarbonsaeureamide |
DE3933573A1 (de) * | 1989-10-07 | 1991-04-18 | Basf Ag | Carbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als herbizide |
DE59106349D1 (de) | 1990-06-23 | 1995-10-05 | Basf Ag | Dicarbonsäureimide als Herbizide. |
DE4023048A1 (de) * | 1990-07-20 | 1992-01-23 | Basf Ag | Dicarbonsaeureimide, verfahren zu ihrer herstellung und ihre verwendung als herbizide |
DE4108181A1 (de) * | 1991-03-14 | 1992-09-17 | Basf Ag | Isoxazol- und isothiazol-5-carbonsaeureamide |
JP3199380B2 (ja) * | 1992-04-02 | 2001-08-20 | スミスクライン・ビーチャム・コーポレイション | 化合物 |
JP3055365B2 (ja) * | 1993-06-30 | 2000-06-26 | 東洋インキ製造株式会社 | 2,5−ジ(アリールアミノ)−3,6−ジヒドロテレフタル酸ジアルキルエステル類の製造法およびこれを中間体とするキナクリドン類の製造法 |
GB9320299D0 (en) | 1993-10-01 | 1993-11-17 | Roussel Lab Ltd | Isoxazole derivatives |
DE19547648A1 (de) | 1995-12-20 | 1997-06-26 | Hoechst Ag | Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate |
DE19610955A1 (de) | 1996-03-20 | 1997-09-25 | Hoechst Ag | Kombinationspräparat, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)- anilid und N-(4-Trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid |
AU3867997A (en) * | 1996-08-27 | 1998-03-19 | Shionogi & Co., Ltd. | Chromene-3-carboxylate derivatives |
DE69739593D1 (de) * | 1996-12-23 | 2009-11-05 | Bristol Myers Squibb Pharma Co | Stickstoffhaltige heterocyclen als faktor xa-hemmer |
EP0946528B1 (en) * | 1996-12-23 | 2003-04-09 | Bristol-Myers Squibb Pharma Company | OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS |
US6020357A (en) * | 1996-12-23 | 2000-02-01 | Dupont Pharmaceuticals Company | Nitrogen containing heteroaromatics as factor Xa inhibitors |
US6187797B1 (en) * | 1996-12-23 | 2001-02-13 | Dupont Pharmaceuticals Company | Phenyl-isoxazoles as factor XA Inhibitors |
EE9900584A (et) * | 1997-06-19 | 2000-08-15 | Dupont Pharmaceuticals Company | Neutraalse P1 spetsiifilisusrühmaga faktori Xa inhibiitorid |
US6339099B1 (en) * | 1997-06-20 | 2002-01-15 | Dupont Pharmaceuticals Company | Guanidine mimics as factor Xa inhibitors |
AU2108099A (en) | 1998-01-30 | 1999-08-16 | Procept, Inc. | Immunosuppressive agents |
GB9804343D0 (en) | 1998-02-27 | 1998-04-22 | Univ Cardiff | Chemical compounds |
JP2002528533A (ja) * | 1998-10-29 | 2002-09-03 | ブリストル−マイヤーズ スクイブ カンパニー | 酵素impdhの新規なインヒビター |
PL352197A1 (en) * | 1999-06-24 | 2003-08-11 | Nihon Nohyaku Co Ltd | Diamide derivatives of heterocyclic dicarboxylic acid, insecticides for agriculture and horticulture and the method of making same |
JP4706810B2 (ja) * | 1999-06-24 | 2011-06-22 | 日本農薬株式会社 | ピリジン環ジカルボン酸ジアミド誘導体及び農園芸用殺虫剤並びにその使用方法 |
WO2001021160A2 (en) * | 1999-09-23 | 2001-03-29 | Axxima Pharmaceuticals Aktiengesellschaft | Carboxymide and aniline derivatives as selective inhibitors of pathogens |
AU7622000A (en) | 1999-10-01 | 2001-05-10 | Institute Of Molecular And Cell Biology | Compounds for the treatment of viral-mediated diseases |
ATE312820T1 (de) * | 1999-10-28 | 2005-12-15 | Trine Pharmaceuticals Inc | Pumpeninhibitoren zur freisetzung von medikamenten |
WO2001032628A1 (en) * | 1999-11-03 | 2001-05-10 | Bristol-Myers Squibb Pharma Company | Cyano compounds as factor xa inhibitors |
US6599926B2 (en) * | 2000-06-23 | 2003-07-29 | Bristol-Myers Squibb Company | Heteroaryl-phenyl substituted factor Xa inhibitors |
RU2181270C1 (ru) | 2000-07-21 | 2002-04-20 | Общество с ограниченной ответственностью "Медицинское предприятие "ХИТ плюс" | Способ повреждения термонетолерантных патологических биоструктур организма теплокровных |
JP2002128768A (ja) * | 2000-10-26 | 2002-05-09 | Dai Ichi Seiyaku Co Ltd | 薬剤排出ポンプ阻害作用を有する化合物 |
JP2002322054A (ja) * | 2001-04-26 | 2002-11-08 | Dai Ichi Seiyaku Co Ltd | 薬剤排出ポンプ阻害薬 |
KR100900304B1 (ko) * | 2001-06-11 | 2009-06-02 | 바이로켐 파마 인코포레이티드 | 플라비 바이러스 감염용 항바이러스제로서의 티오펜 유도체 |
MXPA04000224A (es) * | 2001-07-10 | 2005-07-25 | 4Sc Ag | Novedosos compuestos como agentes antiinflamatorios, inmunomoduladores y antiproliferativos. |
DE10133665A1 (de) * | 2001-07-11 | 2003-01-30 | Boehringer Ingelheim Pharma | Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung |
GB0219896D0 (en) * | 2002-08-27 | 2002-10-02 | Bayer Ag | Dihydropyridine derivatives |
JP4093023B2 (ja) * | 2002-11-15 | 2008-05-28 | コニカミノルタビジネステクノロジーズ株式会社 | 非磁性一成分現像用トナーおよび画像形成方法 |
-
2003
- 2003-12-17 BR BR0317687-8A patent/BR0317687A/pt not_active Application Discontinuation
- 2003-12-17 PL PL377478A patent/PL377478A1/pl not_active Application Discontinuation
- 2003-12-17 AU AU2003299316A patent/AU2003299316A1/en not_active Abandoned
- 2003-12-17 AT AT03799487T patent/ATE450498T1/de not_active IP Right Cessation
- 2003-12-17 PT PT03789317T patent/PT1578741E/pt unknown
- 2003-12-17 JP JP2004561331A patent/JP2006514023A/ja active Pending
- 2003-12-17 KR KR1020057011710A patent/KR101107456B1/ko active IP Right Grant
- 2003-12-17 RU RU2005123401/04A patent/RU2386625C2/ru active
- 2003-12-17 CA CA002509138A patent/CA2509138A1/en not_active Abandoned
- 2003-12-17 MX MXPA05006890A patent/MXPA05006890A/es active IP Right Grant
- 2003-12-17 CN CNA2006101397112A patent/CN1939896A/zh active Pending
- 2003-12-17 CN CNA2003801073550A patent/CN1732147A/zh active Pending
- 2003-12-17 CN CN2003801073546A patent/CN1732163B/zh not_active Expired - Fee Related
- 2003-12-17 EP EP10185827A patent/EP2283898A1/en not_active Withdrawn
- 2003-12-17 DK DK03789317.9T patent/DK1578741T3/da active
- 2003-12-17 RU RU2005123402/04A patent/RU2367650C2/ru not_active IP Right Cessation
- 2003-12-17 ES ES03789317T patent/ES2368735T3/es not_active Expired - Lifetime
- 2003-12-17 EP EP03789317A patent/EP1578741B1/en not_active Expired - Lifetime
- 2003-12-17 WO PCT/EP2003/014433 patent/WO2004056797A1/en active Application Filing
- 2003-12-17 BR BR0317731-9A patent/BR0317731A/pt not_active IP Right Cessation
- 2003-12-17 AT AT03789317T patent/ATE516284T1/de active
- 2003-12-17 JP JP2004561332A patent/JP2006511564A/ja active Pending
- 2003-12-17 NZ NZ541382A patent/NZ541382A/en not_active IP Right Cessation
- 2003-12-17 PL PL377467A patent/PL209303B1/pl unknown
- 2003-12-17 SI SI200332049T patent/SI1578741T1/sl unknown
- 2003-12-17 MX MXPA05006889A patent/MXPA05006889A/es active IP Right Grant
- 2003-12-17 EP EP03799487A patent/EP1581477B1/en not_active Expired - Lifetime
- 2003-12-17 AU AU2003293914A patent/AU2003293914B2/en not_active Ceased
- 2003-12-17 CA CA2509139A patent/CA2509139C/en not_active Expired - Lifetime
- 2003-12-17 DE DE60330391T patent/DE60330391D1/de not_active Expired - Lifetime
-
2005
- 2005-05-30 ZA ZA200504387A patent/ZA200504387B/en unknown
- 2005-06-15 NO NO20052907A patent/NO20052907L/no not_active Application Discontinuation
- 2005-06-15 IL IL169184A patent/IL169184A/en active IP Right Grant
- 2005-06-15 NO NO20052908A patent/NO335748B1/no not_active IP Right Cessation
- 2005-06-17 IL IL169257A patent/IL169257A/en not_active IP Right Cessation
-
2010
- 2010-06-03 JP JP2010127770A patent/JP5300789B2/ja not_active Expired - Fee Related
-
2011
- 2011-09-20 CY CY20111100906T patent/CY1111851T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200621737A (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
IL169184A0 (en) | Aromatic compounds as anti-inflammatory, immunomdulatory and anti-proliferatory agents | |
HRP20090281T1 (en) | 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases | |
TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
WO2006067165A3 (en) | Indolidone derivatives for the treatment or prevention of fibrotic diseases | |
MX2007005694A (es) | Nuevos derivados de betulina, preparacion y uso de los mismos. | |
RS20050432A (en) | Novel aromatic fluoroglycoside derivatives,pharmaceutical products containing said compounds and the use thereof | |
MY134892A (en) | Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use | |
WO2006005609A3 (de) | Substituierte oxindol-derivate und diese enthaltende arzneimittel | |
GB9914486D0 (en) | Medicaments | |
BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
IS8485A (is) | Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki | |
MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
MY139446A (en) | Novel quinoline derivatives | |
MXPA03010761A (es) | Combinaciones farmaceuticas. | |
MXPA05009282A (es) | Derivados de anilina sustituidos. | |
DE60114640D1 (en) | Antithrombosemittel | |
AU2001246999A1 (en) | New neurokinin antagonists for use as medicaments | |
GB0212410D0 (en) | Organic compounds | |
MY139228A (en) | Imidazolinylmethyl aralkylsulfonamides | |
WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents | |
MY139613A (en) | Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders | |
SG171472A1 (en) | Substituted aniline derivatives | |
AU2001244999A1 (en) | Naphthamide neurokinin antagonists for use as medicaments | |
TNSN08242A1 (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |